Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

"Dividend Option" execution timetable

12 Sep 2014 17:53

RNS Number : 5998R
Banco Bilbao Vizcaya Argentaria SA
12 September 2014
Β 

ο»Ώ

Banco Bilbao Vizcaya Argentaria, S.A. (BBVA), in compliance with the Securities Market legislation, hereby proceeds by means of the present document to notify the following:

Β 

Β 

RELEVANT EVENTΒ 

Β 

Β 

BBVA hereby communicates relevant information relating to the free-of-charge capital increase resolved by the General Meeting of BBVA shareholders held on 14th March 2014, under agenda item four, section 4.2, by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented. Accompanying this relevant event notice is an information note related to the Dividend Option.

Β 

Β 

Β 

Β 

Madrid, 12th September 2014

INFORMATION NOTE

Β 

Β 

Β 

The General Meeting of BBVA shareholders held on 14th March 2014, under agenda item four, section 4.2, approved a free-of-charge capital increase for the instrumentation of the system of shareholder remuneration called "Dividend Option", which permits shareholders to elect to receive their remuneration in BBVA shares or, at their election, in cash.

Β 

The execution of such free-of-charge capital increase will be proposed for consideration by BBVA's Board of Directors, so that the Dividend Option may be implemented during October.

Β 

If BBVA's Board of Directors approves the execution of such free-of-charge capital increase in the terms and conditions of the proposal, it is expected to be executed in accordance with the following timetable:

Β 

Β· 24th September 2014: Communication of the number of rights necessary to receive one new share, and the definitive price at which BBVA has committed to purchase rights.

Β 

Β· 26th September 2014 (23:59 Madrid (Spain) time): Record date for allocation of rights.

Β 

Β· 29th September 2014: Rights trading period begins in Spain.

Β· 8th October 2014: Deadline for requesting payment in cash (sale of rights to BBVA).

Β 

Β· 13th October 2014: Rights trading period ends.

Β 

Β· 16th October 2014: Payment date to shareholders who have requested payout in cash (sale of rights to BBVA).

Β 

Β· 23rd October 2014: New shares allocated to shareholders.

Β 

Β· 24th October 2014: Initiation of ordinary trading of the new shares on the Spanish exchanges, subject to obtaining all necessary authorisations.

Β 

Finally, it is estimated that, assuming BBVA's Board of Directors approves the proposal for the execution of such free-of-charge capital increase, the approximate purchase price at which BBVA will purchase rights, in accordance with the formula approved by the General Meeting of BBVA shareholders, will be around 0.08 euros per right.

Β 

Madrid, 12th September 2014

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCKMGMLVZZGDZM
Date   Source Headline
30th Mar 20177:00 amRNSDividend Option Information April 2017
22nd Mar 20178:12 amRNSBBVA completes the acquisition of 9.95% of Garanti
20th Mar 20177:00 amRNSBasel Accord Pillar III
17th Mar 20173:05 pmRNSDividend Option April 2017
17th Mar 20172:58 pmRNSResolutions adopted by the General Meeting
16th Mar 20171:36 pmRNSFinal Terms GMTN Programme
14th Mar 20173:55 pmRNSFinal Terms GMTN Programme
8th Mar 201711:36 amRNSDBRS has assigned BBVA an Issuer Rating
24th Feb 20173:49 pmRNSSupplemental to the Offering Circular GMTN
24th Feb 201710:29 amRNSFinal Terms GMTN Programme
22nd Feb 20177:00 amRNSAcquisition agreement 9,95% of Garanti
14th Feb 20174:07 pmRNSSupplemental to the Offering Circular
14th Feb 20171:26 pmRNSBBVA Annual Report 2016 (spanish version)
14th Feb 20171:22 pmRNSBBVA Annual Report 2016
14th Feb 20179:06 amRNSNotice of AGM
10th Feb 20177:00 amRNSAnnual General Meeting 2017 Call
8th Feb 20173:04 pmRNSFinal Terms - Global Medium Term Note Programme
6th Feb 201710:15 amRNSPost-Stab Notice BBVA EUR 5yr Senior
3rd Feb 20173:34 pmRNSStabilisation Notice
2nd Feb 20178:37 amRNSStabilisation Notice - BBVA T2
1st Feb 20174:36 pmRNSSupplemental to the Offering Circular
1st Feb 20177:16 amRNS4Q16 Results Presentation
1st Feb 20177:10 amRNS4Q16 Results Report
1st Feb 20177:05 amRNSPress Release 4Q16 Results
1st Feb 20177:00 amRNSShareholder Remuneration Policy
27th Jan 20177:48 amRNS4Q16 Results presentation announcement
23rd Jan 20177:46 amRNSRDL Mortgage Floor Clauses
11th Jan 201712:09 pmRNSFinal Terms Global Medium Term Note Programme
5th Jan 201710:10 amRNSPre Stabilisation Notice BBVA EUR 5yr Senior
4th Jan 20173:21 pmRNSPublication of Approved ECP Supplement
28th Dec 20167:00 amRNSSupplemental to the Offering Circular
22nd Dec 20163:51 pmRNSPublication of approved ECP Listing Particulars
22nd Dec 20167:00 amRNSDividend January 2017
21st Dec 20162:23 pmRNSMortgage Floor Clauses
19th Dec 201610:43 amRNSSupplemental to the Offering Circular
1st Dec 20167:48 amRNSSREP capital requirement
25th Nov 20161:24 pmRNSOffering Circular
23rd Nov 20165:44 pmRNSBBVA SA Annual Report 2015
23rd Nov 20165:28 pmRNSBBVA SA Annual Report 2014
23rd Nov 20165:19 pmRNSForm 6-K
23rd Nov 20165:04 pmRNSForm 20-F 2015
7th Nov 20163:32 pmRNSSupplemental to the Offering Circular
4th Nov 201612:18 pmRNSDividend Option
27th Oct 20167:00 amRNS3rd Quarter Results Presentation
27th Oct 20167:00 amRNS3rd Quarter Results Information
27th Oct 20167:00 amRNS3rd Quarter Results
24th Oct 20165:02 pmRNSHR 3Q16 Results presentation announcement
20th Oct 20167:00 amRNSEnding trading period Divend Option October 2016
29th Sep 20167:00 amRNSDividend Option Information October 2016
16th Sep 20161:43 pmRNSDividend Option Calendar October 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.